When was Seragen founded?

Seragen was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is Seragen located?

Seragen is headquartered in Bengaluru, India. It is registered at Helix Biotech Park, IBAB Campus, Electronic City Phase I, Bangalore, Bengaluru, Karnataka, India, 560100.

Who is the current CEO of Seragen?

Srinivas Chari of Seragen. They have also founded 1 company.

Which legal entities is Seragen associated with?

Seragen is associated with SERAGEN BIOTHERAPEUTICS PRIVATE LIMITED.

How many employees does Seragen have?

As of Sep 30, 2026, the latest employee count at Seragen is 42.

Is Seragen a funded company?

Seragen is a funded company, having raised a total of $481K across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 01, 2019.

How much is Seragen worth?

The latest valuation of Seragen is $***** as of Aug 16, 2020.

When was the latest funding round of Seragen?

Seragen's latest funding was a $***** Angel round on Aug 16, 2020, with participation from 25 investors.

What is the annual revenue of Seragen?

Annual revenue of Seragen is less than ₹10 Cr as on Mar 31, 2025

Where does Seragen rank among its competitors?

Seragen ranks 2nd amongst 12 active competitors, of which 5 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was BAIBYS, which secured $4.5M in Aug, 2024.

Who are the top competitors of Seragen?

Seragen's top competitors include AIVF, IVF and BAIBYS. Among them, BAIBYS secured the most recent funding round in August, 2024.

Seragen - 2026 Company Profile, Team, Funding, Competitors & Financials

Seragen is a seed company based in Bengaluru (India), founded in 2018 by Srinivas Chari. It operates as a Platform offering point of care therapeutics and reproductive AI platform to treat infertility. Seragen has raised $481K in funding, with a current valuation of $*****. The company has 12 active competitors, including 5 that are funded. Its top competitors include companies like AIVF, IVF and BAIBYS.

Company Details

Platform offering point of care therapeutics and reproductive AI platform to treat infertility. It provides products and solutions aim to address various fertility and gynecology conditions, including hormonal imbalances, genetic disorders, and miscarriages. Platform helps IVF experts, Ob Gyns, and andrologists treat infertility with a focus on personalized therapeutics.

Website: seragen.co
Registered Address: Helix Biotech Park, IBAB Campus, Electronic City Phase I, Bangalore, Bengaluru, Karnataka, India, 560100

Key Metrics

Founded Year

2018

Location

Bengaluru, India

Stage

Seed

Total Funding

$481K in 2 rounds

Latest Funding Round

Angel, Aug 16, 2020, $*****

Post Money Valuation

$***** as on Aug 16, 2020

Investors

Meena Chitra Kumar & 32 more

Ranked

2^nd among 12 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

42 as on Sep 30, 2026

Similar Companies

AIVF & 12 more

View Seragen's full profile

Seragen is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SERAGEN BIOTHERAPEUTICS PRIVATE LIMITED CIN: U24304KA2018PTC114941 , India, Active	Jul 20, 2018	0 - ₹10 Cr (As on Mar 31, 2025)	-

Seragen has raised a total funding of $481K over 2 rounds. Its first funding round was on Aug 01, 2019. Its latest funding round was a Angel round on Aug 16, 2020 for $*****. 25 investors participated in its latest round. Seragen has 6 institutional investors and 27 angel investors.

Here is the list of recent funding rounds of Seragen:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 16, 2020	8099818	Angel	4935606	3460934	3604610	1905656
Aug 01, 2019	7462693	Grant (prize money)	6163885	4837963	1449078	Startup Karnataka

Access funding benchmarks and valuations. Sign up today!

View details of Seragen's funding rounds and investors

The founders of Seragen is Srinivas Chari. Srinivas Chari is the CEO of Seragen.

Here are the details of Seragen's key team members:

Srinivas Chari: Founder & CEO of Seragen.
Contact Info: 1 email address and 1 phone number

Seragen's Board of Directors

Seragen's board has 4 active members. Velmurugan Balasubramanian, Shrinivas Rangachari, Shrinivas Rangachari and Vasanthi Palanivel are independent board members.

Here is the list of Seragen's board of directors:

Name	Type	Representing	Status	Duration
Velmurugan Balasubramanian	Independent board member	-	Current	8y 2m
cpthnit	Independent board member	-	Current	2y 7m
dmqvkki	Independent board member	-	Current	1y 9m
txrb{cz	Independent board member	-	Current	6y 9m

View details of Seragen's Founder profiles and Board Members

Seragen's employee count trend

Seragen has 42 employees as of Sep 26. Here is Seragen's employee count trend over the years:

Uncover Seragen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Seragen include AIVF, IVF and BAIBYS. Here is the list of Top 10 competitors of Seragen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AIVF 2018, Tel Aviv (Israel), Series A	Provider of AI-based diagnosis platform for IVF treatment	$25M	Insight Partners, Dynamic Loop Capital & 3 others	49/100
2nd	Seragen 2018, Bengaluru (India), Seed	Platform offering point of care therapeutics and reproductive AI platform to treat infertility	$481K	empoWer, C-CAMP & 31 others	40/100
3rd	IVF 2019, Paris (France), Seed	Provider of AI based decision-making tools for IVF professionals	$2.75M	LDV Capital, Entrepreneurs First & 4 others	40/100
4th	BAIBYS 2020, Tel Aviv (Israel), Series A	AI-based sperm selection platform for providers	$6.5M	Firstime, Rohto Group & 1 others	37/100
5th	SpOvum Technologies 2016, Bengaluru (India), Unfunded	Provider of a platform that assists the embryologist in pregnancy	-	-	37/100
6th	U-Ploid Biotechnologies 2024, London (United Kingdom), Funding Raised	Platform offering fertility therapeutics to address age related infertility	-	-	26/100
7th	A.C.H. Ventures 2019, Prague (Czech Republic), Unfunded	Provider of AI based treatment planning solutions for IVF	-	-	24/100
8th	Myma Medical 2020, Daresbury (United Kingdom), Seed	Provider of AI techniques to automate the ICSI process for the IVF clinic	$323K	Deepbridge Capital, LYVA Labs	24/100
9th	Inanna Fertility 2018, Zurich (Switzerland), Deadpooled	Provider of clinical decision support tool for IVF Clinics	-	Alchemist Accelerator, Venture Kick & 1 others	20/100
10th	Polywed 2015, Moscow (Russia), Funding Raised	Data driven technology to determine success rate of IVF treatment	-	K-Startup Grand Challenge	20/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Seragen's competitors? Click here to see the top ones

Founders (largest shareholder) own 83.33%, Enterprises own 0.74%, Angels own 15.91% and Other People own 0.01%. The net worth of Seragen's founders is INR 18Cr as of Aug 16, 2020.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	83.33%	18Cr	5330622	2590690	6349851	5909317
Enterprise	0.74%	16L	0	0	0	0
Angel	15.91%	3.44Cr	7369915	6820765	6321066	2783356
Meena Chitra Kumar	4	6	2	1	4	8
Namrata Swaminathan	2	5	5	7	4	3
Other People	0.01%	18K	0	0	0	0
Total	99.99%	21.6Cr	6707686	1897983	1284558	7532331